Improved survival in chronic lymphocytic leukemia in the past decade: A population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden Academic Article uri icon

Overview

MeSH Major

  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Registries

abstract

  • The observed improvements are likely due to improved therapeutic developments and supportive care. Our findings suggest that elderly chronic lymphocytic leukemia patients might benefit more from the recently introduced drugs in chronic lymphocytic leukemia. Future clinical trials are needed to better define underlying mechanisms of observed heterogeneity in chronic lymphocytic leukemia survival by age and sex, and evaluate the role of newer chronic lymphocytic leukemia therapy in the elderly.

publication date

  • September 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2738718

Digital Object Identifier (DOI)

  • 10.3324/haematol.2009.007849

PubMed ID

  • 19734417

Additional Document Info

start page

  • 1259

end page

  • 65

volume

  • 94

number

  • 9